| Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Carcinoma of lung
|
0.880 | GeneticVariation | UNIPROT | ||||||||
Carcinoma of lung
|
0.880 | CausalMutation | CLINVAR | ||||||||
Juvenile Myelomonocytic Leukemia
|
0.810 | CausalMutation | CLINVAR | ||||||||
Malignant neoplasm of urinary bladder
|
0.800 | GeneticVariation | UNIPROT | ||||||||
Malignant neoplasm of urinary bladder
|
0.800 | CausalMutation | CLINVAR | ||||||||
Malignant neoplasm of lung
|
0.770 | GeneticVariation | UNIPROT | ||||||||
Adenoid Cystic Carcinoma
|
0.700 | CausalMutation | CLINVAR | ||||||||
Stomach Neoplasms
|
0.700 | CausalMutation | CLINVAR | ||||||||
Squamous cell carcinoma of lung
|
0.700 | CausalMutation | CLINVAR | ||||||||
Stomach Carcinoma
|
0.700 | GeneticVariation | UNIPROT | Activated c-Ha-ras oncogene with a guanine to thymine transversion at the twelfth codon in a human stomach cancer cell line. | 3034404 | 1987 | |||||
Stomach Carcinoma
|
0.700 | GeneticVariation | UNIPROT | Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases. | 7773929 | 1995 | |||||
B-CELL MALIGNANCY, LOW-GRADE
|
0.010 | GeneticVariation | BEFREE | Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene. | 9139869 | 1997 | |||||
Chronic Lymphocytic Leukemia
|
0.010 | GeneticVariation | BEFREE | Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene. | 9139869 | 1997 | |||||
Diffuse Large B-Cell Lymphoma
|
0.010 | GeneticVariation | BEFREE | Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene. | 9139869 | 1997 | |||||
Adult Diffuse Large B-Cell Lymphoma
|
0.010 | GeneticVariation | BEFREE | Altogether, one diffuse large B-cell lymphoma and one B-cell chronic lymphocytic leukemia (B-CLL) harbored a mutation (G12S and G12A, respectively) in the K-ras gene, and one B-CLL harbored a mutation (Q61R) in the N-ras gene. | 9139869 | 1997 | |||||
Non-Small Cell Lung Carcinoma
|
0.800 | CausalMutation | CLINVAR | BRAF and RAS mutations in human lung cancer and melanoma. | 12460918 | 2002 | |||||
Non-Small Cell Lung Carcinoma
|
0.800 | CausalMutation | CLINVAR | BRAF and RAS mutations in human lung cancer and melanoma. | 12460918 | 2002 | |||||
Non-Small Cell Lung Carcinoma
|
0.800 | CausalMutation | CLINVAR | BRAF and RAS mutations in human lung cancer and melanoma. | 12460918 | 2002 | |||||
Stomach Carcinoma
|
0.700 | GeneticVariation | UNIPROT | BRAF and KRAS mutations in stomach cancer. | 14534542 | 2003 | |||||
Gestational Trophoblastic Neoplasms
|
0.010 | GeneticVariation | BEFREE | In contrast, a specific sensor probe for the TGT (G12C) mutant detected GAT (G12D), AGT (G12S), and GTT (G12V) mutants in addition to the TGT mutant. | 14718395 | 2004 | |||||
Non-Small Cell Lung Carcinoma
|
0.800 | CausalMutation | CLINVAR | KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. | 15696205 | 2005 | |||||
Non-Small Cell Lung Carcinoma
|
0.800 | CausalMutation | CLINVAR | KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. | 15696205 | 2005 | |||||
Non-Small Cell Lung Carcinoma
|
0.800 | CausalMutation | CLINVAR | KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. | 15696205 | 2005 | |||||
Colorectal Neoplasms
|
0.700 | CausalMutation | CLINVAR | Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma. | 16361624 | 2005 | |||||
Colorectal Neoplasms
|
0.700 | CausalMutation | CLINVAR | Randomized phase II trial of the clinical and biological effects of two dose levels of gefitinib in patients with recurrent colorectal adenocarcinoma. | 16361624 | 2005 |